Identification of the minimal active sequence of an anti-influenza virus peptide.

Brandt Lab // Publications // Apr 01 2011

PubMed ID: 21220525

Author(s): Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. Identification of the minimal active sequence of an anti-influenza virus peptide. Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3. doi: 10.1128/AAC.01428-10. Epub 2011 Jan 10. PMID 21220525

Journal: Antimicrobial Agents And Chemotherapy, Volume 55, Issue 4, Apr 2011

The antiviral peptide, entry blocker (EB), inhibits influenza virus replication by preventing attachment to cells. Here, we identified the minimal and optimal EB sequence that retained antiviral activity with a 50% inhibitory concentration (IC(50)) and 50% effective concentration (EC(50)) similar to those of the full-length EB peptide and several truncated variants that possessed up to 10-fold lower IC(50)s. These data have implications for improving the antiviral efficacy of EB-derived peptides while decreasing production costs and easing synthesis.